PharmaReports: Oncology
LeadDiscovery offers full reports in selected areas of the pharmaceutical and biotech sector.
Each of the reports below has been especially selected by LeadDiscovery. Browse the reports or try our search engine.
All reports focusing on oncology are featured here with the exception of antibody, immunological or cell therapeutic approaches which are listed on the Cancer Immunotherapy channel.
Showing results 1 - 50 of 176
- Biomarkers: A Market Briefing
- The Emerging Cancer Vaccine Market
- Womens Health: Worldwide Prescription Drug Markets
- The Protein Therapeutics Market: The Science and Business of a Growing Sector
- Mens Health: The Market for Current and Emerging Drug Therapies
- Medical Imaging Markets: Radiography
- The Global Market for Adjunctive Therapies in Cancer
- The Impact of the Phase III Pipeline: Future Projections and Market Disruptions
- The Worldwide Market for Prescription Dermatological Drugs
- Cancer Therapeutics: The Worldwide Market
- Cancer Stem Cells: Emerging Therapeutic, Diagnostics and Market Opportunities
- Drug Delivery in Cancer - technologies, markets and companies
- Cell Therapy - Technologies, Markets and Companies
- Cancer Diagnostic Testing World Markets
- Cancer Therapeutics Markets
- Mammography World Markets
- Women\'s Health: Diagnostic Testing
- Medical Imaging Markets
- Cytology and HPV Testing World Markets
- Therapeutic Monoclonal Antibodies, 2006-2011
- Pipeline Insight: Hematological Malignancies - Pursuit for the next blockbuster intensifies
- Stakeholder Opinions: Small Cell Lung Cancer and Malignant Mesothelioma
- Early Toxicology: Markets and Approaches
- Melanoma - Lucrative commercial opportunities persist
- Pricing and Reimbursement in Oncology
- Gynecological Cancers - Niche opportunities in advanced disease
- Non-Small Cell Lung Cancer
- Biotech Drug Delivery Systems - Key Company Intelligence & Market Outlook to 2012
- Colorectal Cancer - Shaping the future dynamics of colorectal cancer management
- Molecular Targeted Cancer Therapies - More drugs on the market, more targets in the pipeline
- Supportive Care in Cancer Treatment - Some first-generation products proving difficult to dislodge
- Pipeline Insight: Breast Cancer - A diverse and increasingly crowded pipeline
- Pipeline Insight: Cancer Overview Emerging Therapeutic and Commercial Opportunities
- From Blockbuster to Nichebuster
- Commercial Insight Top 20 Cancer Therapeutics
- Ovarian Cancer: Growing importance as secondary indication for targeted therapies
- Monoclonal Antibodies 2007
- The Global Protein Therapeutics Market
- Cancer Therapeutics 2006
- Biogenerics
- Cancer Vaccines Measuring Market Potential
- Acute Leukemias - Persistent unmet needs confer significant commercial opportunity
- Gastric Cancer - Targeted Therapies Home In On a Neglected Tumor Type
- Preclinical Cancer Therapeutics 2007
- Chemotherapy Market Insights, 2006-2016
- Renal Cell Carcinoma - Novel Targeted Treatments to Fill the Void
- Therapeutic Vaccines
- Generic Cancer Market - New Legislation and a Wave of Patent Expiries to Transform the Market
- Biogenerics 2005: A New Level of Complexity
- Myelodysplastic Syndrome - An underserved population offers commercial opportunity
Browse our theraputic areas for other entries:
- Oncology
- Cancer Immunotherapy
- Immunology & Inflammatory Diseases
- Infectious Diseases
- Psychiatric, Addictive & Sleep Disorders
- Pain
- Neurodegenerative & Neuroelectrophysiological Disorders
- Metabolic & Hormonal Disorders
- Cardiovascular Disorders
- GenitoUrinary Tract Disorders
- Technology
- Diagnostics & Devices
- Other Theraputic Areas, Pharmaceutical Strategy and Development